Table 4.
Overall flow of PrEP cascade in breastfeeding women in care in 8 clinics (March 2022–July 2023)
| Clinic | HIV antenatal prevalence (2021) | Number of immunization visits per clinic* | Number of breastfeeding mother tested & counseled for HIV | Estimated number of HIV-negative mothers eligible for PrEP** | Number and percentage of PrEP initiations | Number and percentage of PrEP refill |
|---|---|---|---|---|---|---|
| MOU/CHC 1 | 13% | 574 | 37 | 36 | 8 (22%) | 2 (25%) |
| MOU/CHC 2 | 34% | 271 | 151 | 151 | 15 (10%) | 3 (20%) |
| MOU/CHC 3 | 10% | 415 | 118 | 118 | 2 (2%) | 0 (0%) |
| Clinic 1 | 28% | 10 040 | 311 | 311 | 39 (13%) | 16 41%) |
| Clinic 2 | 35% | 12 847 | 135 | 134 | 37 (28%) | 7 (19%) |
| Clinic 3 | 38% | 4 905 | 149 | 149 | 22 (15%) | 13 (59%) |
| Clinic 4 | 24% | 1 567 | 302 | 302 | 47 (16%) | 0 (0%) |
| Clinic 5 | 33% | 3 701 | 114 | 114 | 9 (8%) | 4 (44%) |
| Total | 34 320 | 1 317 | 1 315 | 179 (14%) | 45 (25%) | |
*
Number of BF women attending is unknown, the number of immunization visits is used as a proxy
**
Average number of tests for breastfeeding women is 1